The Mosaic Company
MOS
$21.40
-0.05%
The Mosaic Company is a leading global producer and marketer of concentrated phosphate and potash crop nutrients, operating within the Agricultural Inputs industry. As one of the world's largest integrated producers, its distinct competitive identity stems from its vertical integration, owning phosphate rock mines in the US and potash mines in Canada, coupled with a major fertilizer distribution network in Brazil. The current investor narrative is heavily influenced by geopolitical supply shocks, as recent news highlights the closure of the Strait of Hormuz stranding a significant portion of global fertilizer supply, which is seen as creating a substantial margin opportunity for North American producers like Mosaic with secure local inputs, juxtaposed against concerns over cyclical commodity price pressures and demand softness.…
MOS
The Mosaic Company
$21.40
Investment Opinion: Should I buy MOS Today?
Rating: HOLD. The core thesis is that while Mosaic is fundamentally cheap and positioned for a potential supply-driven rally, the overwhelming negative price momentum and deteriorating financials advise waiting for signs of stabilization before committing capital. Analyst sentiment is neutral-to-cautious, reflecting this standoff.
Supporting evidence includes a forward P/E of 11.00x, which is low on an absolute basis and implies a significant earnings recovery. The Price-to-Sales ratio of 0.63x and EV/EBITDA of 4.84x are deep value metrics. However, these are countered by a -7.55% YoY revenue decline, a gross margin drop of 451 basis points in three quarters, and deeply negative TTM free cash flow of -$534.6M. The stock trades just 13% above its 52-week low, highlighting extreme pessimism.
The thesis would upgrade to BUY if the company demonstrates a quarter of sequential margin improvement or a return to positive free cash flow, confirming the Hormuz supply shock benefit. It would downgrade to SELL if the price breaks decisively below the $21.17 support level on high volume or if TTM free cash flow deteriorates further. Relative to its history and sector, the stock is undervalued, but it is fairly valued given the current cyclical risks and lack of a near-term earnings catalyst.
Sign up to view all
MOS 12-Month Price Forecast
Mosaic presents a classic value trap versus deep value opportunity dilemma. The valuation is compellingly cheap, but the fundamental and technical momentum is decisively negative. The 30% probability bull case offers meaningful upside if the supply shock catalyst materializes, but the 50% probability base case suggests sideways action is more likely as the market waits for proof of a turnaround. The stance is neutral due to the high uncertainty; the stock is not a buy until it demonstrates an inflection in free cash flow or price stabilizes above its 50-day moving average. Confidence is medium as the wide analyst EPS range ($1.91 to $2.56) underscores the lack of clarity on the earnings trajectory.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on The Mosaic Company's 12-month outlook, with a consensus price target around $27.82 and implied upside of +30.0% versus the current price.
Average Target
$27.82
6 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
6
covering this stock
Price Range
$17 - $28
Analyst target range
A limited set of six analysts provide coverage for the stock, with consensus sentiment leaning neutral to cautious, as evidenced by recent institutional rating actions including downgrades from B of A Securities (Buy to Neutral) and Barclays (Overweight to Equal Weight). The average target price is implied through estimated metrics, with an average EPS estimate of $2.23 and average revenue estimate of $11.6 billion, but a specific consensus price target and implied upside are not available in the provided data. The target range is wide, with EPS estimates spanning from $1.91 to $2.56, signaling high uncertainty around the earnings recovery trajectory; the low end likely prices in continued margin pressure and demand weakness, while the high end assumes successful realization of the geopolitical supply shock benefits and a firmer price environment.
Bulls vs Bears: MOS Investment Factors
The bull case for Mosaic rests on its extreme valuation discount and a potential geopolitical catalyst that could improve margins, while the bear case is driven by deteriorating fundamentals, negative cash flow, and persistent downward momentum. Currently, the bearish evidence appears stronger, given the concrete data showing revenue decline, margin compression, and accelerating price depreciation. The single most important tension in the investment debate is whether the potential margin benefit from the Hormuz Strait supply shock will materialize and be sufficient to offset the clear cyclical downturn in fertilizer demand and pricing that is currently pressuring financials. The stock's fate hinges on this external catalyst versus internal fundamental weakness.
Bullish
- Deeply Undervalued on Key Metrics: The stock trades at a trailing P/E of 14.14x and a forward P/E of 11.00x, both near the lower end of its historical range. Its EV/EBITDA of 4.84x and P/S of 0.63x are significantly below typical commodity producer multiples, indicating a severe discount if the current cyclical trough is temporary.
- Geopolitical Supply Shock Catalyst: Recent news highlights the closure of the Strait of Hormuz, which has stranded a third of global fertilizer supply. As a North American producer with secure local inputs, Mosaic is positioned to capture a significant margin opportunity from this supply disruption, which is not yet reflected in its depressed share price.
- Strong Balance Sheet Amid Downturn: The company maintains a solid current ratio of 1.32 and a manageable debt-to-equity ratio of 0.44. This financial stability provides a cushion during the commodity price downturn and allows it to potentially capitalize on distressed opportunities.
- Analyst EPS Growth Expectations: Analysts project a forward EPS of $2.23, which implies a significant earnings recovery from the current depressed level. The wide range of estimates ($1.91 to $2.56) reflects uncertainty, but the average points to a near-doubling of earnings power, supporting the forward P/E discount.
Bearish
- Severe Cyclical Downturn in Fundamentals: Q4 2025 revenue declined 7.55% YoY to $2.60B, and gross margin compressed to 14.17% from 18.63% in Q1 2025. This demonstrates significant pressure on both pricing and profitability, driven by softening end-market demand.
- Persistent Negative Free Cash Flow: Trailing-twelve-month free cash flow is deeply negative at -$534.6 million. This cash burn indicates the company is not generating sufficient internal cash to fund operations and capital expenditures, which could pressure the balance sheet or dividend if prolonged.
- Accelerating Negative Momentum & Underperformance: The stock is down 26.61% over the past three months and 8.30% over the past month, severely underperforming the SPY by -35.03 and -13.90 percentage points, respectively. This accelerating decline shows no sign of a near-term reversal and indicates strong selling pressure.
- Analyst Downgrades & Cautious Sentiment: Recent institutional actions include downgrades from B of A Securities (Buy to Neutral) and Barclays (Overweight to Equal Weight). This reflects professional skepticism about a near-term recovery, aligning with the stock's poor relative strength and fundamental deterioration.
MOS Technical Analysis
The prevailing price trend is a pronounced and sustained downtrend, with the stock down 37.24% over the past year. The current price of $21.76 positions it near the bottom of its 52-week range, trading at approximately 13% of the range above the $21.17 low, which suggests the stock is deeply oversold and may represent a value opportunity, though it also risks being a 'falling knife' amid persistent negative momentum. Recent momentum remains sharply negative and is accelerating, with the stock down 26.61% over the past three months and 8.30% over the past month, significantly underperforming the SPY's gains of 8.42% and 5.6% over the same periods, indicating severe relative weakness and no signs of a near-term reversal. Key technical support is clearly defined at the 52-week low of $21.17, while resistance sits far above at the 52-week high of $38.23; a breakdown below support could trigger another leg down, while any recovery would face substantial overhead supply. The stock's beta of 0.797 indicates it is about 20% less volatile than the broader market, which is atypical for a commodity stock but may reflect its large-cap status and integrated model, though this has not shielded it from a severe 42.45% maximum drawdown.
Beta
0.80
0.80x market volatility
Max Drawdown
-43.4%
Largest decline past year
52-Week Range
$21-$38
Price range past year
Annual Return
-39.5%
Cumulative gain past year
| Period | MOS Return | S&P 500 |
|---|---|---|
| 1m | -12.9% | +3.3% |
| 3m | -27.3% | +6.9% |
| 6m | -10.6% | +12.4% |
| 1y | -39.5% | +23.4% |
| ytd | -14.5% | +7.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MOS Fundamental Analysis
Revenue trajectory shows significant volatility and recent pressure, with Q4 2025 revenue at $2.60 billion representing a 7.55% year-over-year decline, and the multi-quarter trend from the income statement reveals a peak in Q3 2025 at $3.45 billion before the drop, indicating softening end-market demand and potentially lower realized prices. The company remains profitable but with compressed margins, citing Q4 2025 net income of $162.2 million and a gross margin of 14.17%, which is down substantially from the 18.63% gross margin in Q1 2025, reflecting the cyclical downturn in fertilizer pricing and higher input costs. Financial health is mixed, with a strong current ratio of 1.32 and a moderate debt-to-equity ratio of 0.44 indicating a manageable balance sheet, but free cash flow is a major concern, with TTM free cash flow deeply negative at -$534.6 million and ROE a modest 4.47%, suggesting the company is not currently generating sufficient internal cash to fund operations and capital expenditures without drawing on reserves or financing.
Quarterly Revenue
$2.6B
2025-12
Revenue YoY Growth
-0.07%
YoY Comparison
Gross Margin
+0.14%
Latest Quarter
Free Cash Flow
$-534600000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MOS Overvalued?
Given Net Income is positive, the primary valuation metric selected is the Price-to-Earnings (PE) ratio. The trailing PE is 14.14x, while the forward PE is significantly lower at 11.00x, based on estimated EPS of $2.23; this gap implies the market expects a meaningful recovery in earnings over the next twelve months. Compared to sector averages, Mosaic trades at a discount based on its Price-to-Sales ratio of 0.63x, which is well below typical commodity producer multiples, and its EV/EBITDA of 4.84x also suggests a bargain-basement valuation if cyclical trough earnings are assumed. Historically, the stock's current trailing PE of 14.14x sits well below its own historical range observed in the data, which has seen peaks above 57x during low-earnings periods and troughs near 5x; this positioning near the lower end of its historical band suggests the market is pricing in pessimistic expectations, potentially offering a value entry point if the cycle is believed to be near a bottom.
PE
14.1x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -702x~58x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
4.8x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are pronounced. The company is burning cash at a rate of -$534.6M TTM, which is unsustainable and threatens its financial flexibility if the downturn persists. Gross margins have compressed from 18.63% to 14.17% over the last three quarters, indicating significant pricing pressure and rising input costs. While the balance sheet is currently stable with a D/E of 0.44, continued negative free cash flow could force asset sales, dividend cuts, or increased leverage.
Market & Competitive Risks center on its deep cyclicality and valuation. The stock trades at a significant discount to historical multiples (P/E of 14.14x vs. historical peaks above 57x), but this compression could persist or worsen if the commodity cycle remains in a downswing. The stock's beta of 0.797 suggests it is less volatile than the market, yet it has suffered a 42.45% maximum drawdown, highlighting its vulnerability to sector-specific shocks rather than broad market moves. The recent analyst downgrades signal a loss of institutional confidence, which could limit buying interest.
Worst-Case Scenario involves a prolonged fertilizer price slump exacerbated by a global economic slowdown reducing agricultural demand. This would lead to further margin compression, sustained negative free cash flow eroding the balance sheet, and a breakdown of the key technical support at the 52-week low of $21.17. In this adverse scenario, the stock could realistically re-test its recent lows, implying a downside of approximately -5% from the current price of $21.76. A more severe bear case, aligned with the lower end of the earnings estimate range ($1.91 EPS), could see the stock fall toward $20, representing a downside of -8% to -10%.
FAQ
The key risks are, in order of severity: 1) Financial Risk: Sustained negative free cash flow (-$534.6M TTM) threatens the balance sheet and dividend sustainability. 2) Commodity Price Risk: The company is exposed to volatile phosphate and potash prices, with recent gross margin compression from 18.63% to 14.17% showing clear downside. 3) Operational/Macro Risk: Soft global agricultural demand could prolong the earnings downturn. 4) Sentiment/Momentum Risk: The stock is in a pronounced downtrend, down 37.24% over the past year, and recent analyst downgrades reflect waning institutional support.
The 12-month forecast is bifurcated, with a 50% probability base case target range of $24-$28, a 30% probability bull case target of $32-$38, and a 20% probability bear case target of $18-$21. The base case, which is most likely, assumes earnings stabilize near the analyst consensus EPS of $2.23 but valuation multiples remain depressed due to cyclical concerns. The bull case depends on the Hormuz supply shock materially boosting margins, while the bear case involves a breakdown of key support at $21.17 and worsening fundamentals. The wide $20 range between bull and bear targets reflects the high uncertainty inherent in this cyclical commodity stock.
MOS is statistically undervalued based on traditional metrics. Its trailing P/E of 14.14x and forward P/E of 11.00x are near the low end of its historical range. Its Price-to-Sales ratio of 0.63x and EV/EBITDA of 4.84x are well below sector averages for commodity producers. However, this 'cheapness' is justified by the cyclical downturn, as evidenced by a 7.55% YoY revenue decline and margin compression. The market is pricing in a continuation of weak earnings, making the stock fairly valued relative to its near-term prospects, though deeply undervalued if a cyclical recovery occurs.
MOS is a high-risk, high-potential-reward stock that is not a good buy for most investors at this moment. For a speculative, value-oriented investor willing to tolerate significant volatility, its deep valuation discount (P/S of 0.63x, Forward P/E of 11.00x) and geopolitical catalyst offer appeal. However, the deteriorating fundamentals (negative $534.6M FCF, declining margins), severe negative price momentum (-37.24% YoY), and neutral-to-cautious analyst sentiment advise caution. It could become a good buy if the price stabilizes above $21.17 and the company reports a quarter of improving cash flow.
MOS is unsuitable for short-term trading due to its high volatility within a downtrend (42.45% max drawdown) and lack of near-term positive catalysts. It is a speculative long-term investment for investors betting on a multi-year commodity cycle recovery. The suggested minimum holding period is 3-5 years to potentially ride out the cyclical trough and benefit from the eventual upturn. The stock does not pay a sufficiently secure dividend (3.67% yield) to qualify as an income hold, and its beta of 0.797 is misleading given its severe sector-specific volatility.